Melissa Watson

Doctor of Medicine,  Cleveland Clinic 

Location: Germany

Consulting Services

Career Advice and Mentoring Case Consulting Scientific Writing Sales and Marketing

Areas Of Interest

Rutledge Lethal Multiple Congenital Anomaly Syndrome Mouth Rinses Denervation, Muscle Reconstitution, Family RNA, Non Coding Female Contraceptive Agents Dehydrogenase, Glucose Gaucher Disease, Chronic BW 48-80 AM 715 para-Hydroxynorephedrine Meristem Harbor Seals Head Injuries Burkholderia mallei Canine Diseases Dosimetries, Film Badge Sterile Alpha Motifs Cytoxicities, Antibody-Dependent Cell Azospirillum brasilense Kinases, mTOR Serine-Threonine Medicine, Folk Malonate-Semialdehyde Dehydrogenase (Acetylating) Toxemia D-T4 Thyroid Hormone Carinatums, Pectus Old Age Home ST1571 ECoGs, Intraoperative Selection, Food Maxillofacial Surgeon

Professional Narrative

Dr. Melissa Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 2011
Executive Director, Harvard Med 1997

Education

Doctor of osteopathic medicine, Perelman School of Medicine 2010
Bachelor of science in nursing, Yale School of Medicine 1992

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02